Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin safety and pharmacokinetics in chronic heart failure
ACTRN12617001418369Phase 4Recruiting
- Sponsor
- St Vincent's Hospital Sydney
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of metformin in chronic heart failure (CHF) (3 cohorts), sponsored by St Vincent's Hospital Sydney. Primary endpoints: Safety of metformin in patients with heart failure, Preliminary safety in patients with type 2 diabetes mellitus, heart failure and already on metformin and 1 more. Started Sep 2017; status: recruiting.
02
Drugs
metformin
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on ACTRN12617001418369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001418369.